Evidence map›Paper›PMID 36730749›Full record

Trial reportJournal of child and adolescent psychopharmacology2023

Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day.

Stephen V Faraone, Ann C Childress, Roberto Gomeni, Eman Rafla, Judith C Kando, Lori Dansie, Payal Naik, Antonio Pardo

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of child and adolescent psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Stephen V FaraoneSUNY Upstate Medical University, Syracuse, New York, USA.
Ann C ChildressCenter for Psychiatry and Behavioral Medicine, Inc., Las Vegas, Nevada, USA.ORCID 0000-0001-5782-7891
Roberto GomeniPharmacoMetrica, La Fouillade, France.
Eman RaflaTris Pharma, Inc., Monmouth Junction, New Jersey, USA.
Judith C KandoTris Pharma, Inc., Monmouth Junction, New Jersey, USA.
Lori DansieTris Pharma, Inc., Monmouth Junction, New Jersey, USA.
Payal NaikTris Pharma, Inc., Monmouth Junction, New Jersey, USA.ORCID 0000-0002-9965-2855
Antonio PardoTris Pharma, Inc., Monmouth Junction, New Jersey, USA.
PharmaSeq (United States) · USCenter for Psychiatry and Behavioral Medicine · USSUNY Upstate Medical University · US

Funding

SLE Treatment with N-acetylcysteineU01AR076092 · NIAMS · UPSTATE MEDICAL UNIVERSITY · PI Michael P McDermott, Andras Perl · 2020 to 2026
$7.9M
Discoveries in ADHD genomics: Help or hype in clinical settings?R01MH116037 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DOYLE, ALYSA E · 2019 to 2023
$4.4M
NIAMS NIH HHS U01 AR076092NIMH NIH HHS R01 MH116037
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsAmphetamineChildDelayed-Action PreparationsDose-Response Relationship, DrugDouble-Blind MethodHumansPsychiatric Status Rating ScalesSuspensionsTreatment OutcomeAmphetamineCentral Nervous System StimulantsDelayed-Action PreparationsSuspensionsamphetamineattention-deficit/hyperactivity disordereffect sizeextended-releaselaboratory schoolliquid formulationoral suspension

Identifiers

PMID36730749
PMCPMC9963474
OpenAlexW4318955568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.